US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

Inhalon Biopharma's inhaled RSV antibody treatment will enter human trials marking a potential breakthrough in respiratory ...

Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

Recent studies have provided valuable insights into the pathophysiology of febrile ... viral infections such as Influenza A and Respiratory Syncytial Virus (RSV)[3]. This seasonal trend ...

Respiratory syncytial virus (RSV). Nemours KidsHealth. Is it a cold, the flu, an RSV infection, or COVID-19? UpToDate. Patient education: bronchiolitis and RSV in infants and children (beyond the ...

The respiratory syncytial virus was the most frequent offender ... A discussion of the various complex factors involved in the pathogenesis of chronic bronchitis is beyond the scope of this ...

The work described in this thesis is aimed to create more insight into the role of m6A and its regulatory proteins in innate- and adaptive immune cell function, anti-viral immunity against RSV and ...

Many health experts have compared HMPV to Respiratory Syncytial Virus (RSV), which can affect all age groups but is more common in children. According to the World Health Organization (WHO), HMPV ...

A nationwide surge in flu, COVID-19, RSV and norovirus infections is fueling concerns of a possible virus "quademic." Or is it just winter? The three respiratory viruses plus norovirus ...

Both Lehigh Valley and St. Luke’s University health networks report increased hospitalizations related to influenza and respiratory syncytial virus, two of the most common respiratory infections ...

Cases of RSV across the country are considered "very high," as rates of other acute respiratory illnesses are also high, the CDC reported Monday. Here's what to know about RSV. Iowa currently is ...